Difference between revisions of "Perfusion, Diffusion and Flow-MRI Biomarker Ctte"
Jump to navigation
Jump to search
| (276 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | :Co-chairs: Michael Boss, PhD; John Kirsch, PhD; Daniel Barboriak, MD | |
| − | |||
| − | |||
| − | |||
| − | + | * [http://tinyurl.com/QIBA-PDF-MRI-Roster Roster] | |
| − | *[ | ||
| − | |||
| − | + | '''NOTICE''': This committee has been [[Committee Sunset Process|dissolved]] as of June 6, 2018. | |
| − | + | * PDF served as the launching point for work on [[DWI MR Biomarker Ctte | DWI]], [[DCE MRI Biomarker Ctte |DCE]], and [[DSC MRI Biomarker Ctte | DSC]], which now have their own Biomarker Committees, as well as DTI. | |
| − | + | * This page is persisted to provide access to earlier call summaries and profiling materials | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | *[[ | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | * | ||
| − | |||
| − | *[[Media: | + | ==Recent PDF-MRI Meetings== |
| − | *[[ | + | |
| + | '''Approved call summaries:''' | ||
| + | |||
| + | *[[Media:2018_05-09_QIBA_PDF-MRI_Biomarker_Cmte_Call_Summary-FINAL.pdf|May 9, 2018]] | ||
| + | *[[Media:2018_04-25_QIBA_PDF-MRI_Biomarker_Cmte_Call_Summary-FINAL.pdf|April 25, 2018]] | ||
| + | *[[Media:2018_02-14_QIBA_PDF-MRI_Biomarker_Cmte_Call_Summary-FINAL.pdf|February 14, 2018]] | ||
| + | |||
| + | '''''[[PDF BC Call Summaries Archive]]''''' | ||
==Reference Materials== | ==Reference Materials== | ||
| − | *[[Media: | + | *[[Media:QIBA Profile compliance clinical environment-30AUGUST2013.pdf|QIBA Profile Compliance - Clinical Environment]] ''30-August-2013'' |
| + | *[[Media:PDF MRI TC Update 20130130A.pdf|PDF-MRI Technical Committee Report to the Steering Committee - 01.31.2013]] | ||
*[[Media:MDACC QIBA Scans 20090215 Summary Plot.pdf|MDACC QIBA Scans 20090215 Summary Plot]] | *[[Media:MDACC QIBA Scans 20090215 Summary Plot.pdf|MDACC QIBA Scans 20090215 Summary Plot]] | ||
| Line 40: | Line 30: | ||
*[[Media:UC_MDACC_Comparison_20090902Tcon.xls|MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson]] | *[[Media:UC_MDACC_Comparison_20090902Tcon.xls|MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson]] | ||
| − | |||
| − | *[[ | + | ==QIBA / QuIC-ConCePT (IMI) Collaboration== |
| + | |||
| + | *[[QIBA / QuIC-ConCePT Call Summaries]] | ||
| + | *[[Ambition Levels for Collaboration]] | ||
| + | *[[Clinical Trials Collaboration]] | ||
Latest revision as of 16:44, 21 December 2023
- Co-chairs: Michael Boss, PhD; John Kirsch, PhD; Daniel Barboriak, MD
NOTICE: This committee has been dissolved as of June 6, 2018.
- PDF served as the launching point for work on DWI, DCE, and DSC, which now have their own Biomarker Committees, as well as DTI.
- This page is persisted to provide access to earlier call summaries and profiling materials
Recent PDF-MRI Meetings
Approved call summaries:
Reference Materials
- QIBA Profile Compliance - Clinical Environment 30-August-2013
- PDF-MRI Technical Committee Report to the Steering Committee - 01.31.2013
- Siemens-QIBA Protocol -- July 1, 2009 -- Dr David Purdy
- MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson